Australia markets closed

Zylox-Tonbridge Medical Technology Co., Ltd. (2190.HK)

HKSE - HKSE Delayed price. Currency in HKD
Add to watchlist
14.440+0.080 (+0.56%)
At close: 04:08PM HKT
Currency in HKD

Valuation measures4

Market cap (intra-day) 4.79B
Enterprise value 1.37B
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)20.32
Price/book (mrq)1.30
Enterprise value/revenue 7.69
Enterprise value/EBITDA -7.36

Trading information

Stock price history

Beta (5Y monthly) N/A
52-week change 3-75.93%
S&P500 52-week change 3-11.93%
52-week high 360.800
52-week low 310.020
50-day moving average 312.009
200-day moving average 321.264

Share statistics

Avg vol (3-month) 3104.18k
Avg vol (10-day) 3107.15k
Shares outstanding 5324.62M
Implied shares outstanding 6N/A
Float 8115.65M
% held by insiders 136.27%
% held by institutions 126.28%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in CNY.

Fiscal year

Fiscal year ends 31 Dec 2021
Most-recent quarter (mrq)31 Dec 2021

Profitability

Profit margin -112.24%
Operating margin (ttm)-122.63%

Management effectiveness

Return on assets (ttm)-7.27%
Return on equity (ttm)-11.19%

Income statement

Revenue (ttm)177.91M
Revenue per share (ttm)0.60
Quarterly revenue growth (yoy)317.00%
Gross profit (ttm)131.88M
EBITDA -208.48M
Net income avi to common (ttm)-199.69M
Diluted EPS (ttm)N/A
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)2.93B
Total cash per share (mrq)8.82
Total debt (mrq)9.4M
Total debt/equity (mrq)0.30
Current ratio (mrq)31.14
Book value per share (mrq)9.47

Cash flow statement

Operating cash flow (ttm)-116.21M
Levered free cash flow (ttm)-129.84M